| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |